Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
42.97
-0.95 (-2.16%)
Jun 6, 2025, 2:45 PM CST
SHE:002653 Revenue
Haisco Pharmaceutical Group had revenue of 892.01M CNY in the quarter ending March 31, 2025, with 18.60% growth. This brings the company's revenue in the last twelve months to 3.86B, up 10.84% year-over-year. In the year 2024, Haisco Pharmaceutical Group had annual revenue of 3.72B with 10.92% growth.
Revenue (ttm)
3.86B
Revenue Growth
+10.84%
P/S Ratio
12.35
Revenue / Employee
723.48K
Employees
5,337
Market Cap
47.69B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.72B | 366.28M | 10.92% |
Dec 31, 2023 | 3.36B | 339.78M | 11.27% |
Jan 1, 2023 | 3.02B | 241.98M | 8.73% |
Jan 1, 2022 | 2.77B | -556.28M | -16.71% |
Dec 31, 2020 | 3.33B | -607.74M | -15.44% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |